A joint research project in Japan and Australia may have made important progress in developing a blood test that could help doctors detect who might is at risk for Alzheimer’s disease.
Researchers at the Japanese National Center for Geriatrics and Gerontology and the University of Melbourne claim that the test, which can detect a toxic protein known as amyloid beta, linked to Alzheimer‘s, was more than 90 percent accurate in research involving around 370 people.
Currently, Alzheimer’s tests are invasive, expensive and may only show results when the disease has already started to progress.
If results can be replicated, the new test could give insight into changes occurring in the brain that relate to Alzheimer’s disease, which may help doctors' ability to accurately detect signs of the disease early.
Read the Reuters report
